Brisou, G., Bachy, E., Gat, E., Cartron, G., Houot, R., Sesques, P., Gros, F., Blasi, R. D., Bras, F. L., Castilla-Llorente, C., Bories, P., Rochelle, L. D. L., Loschi, M., Morschhauser, F., Rossi, C., Guidez, S., Choquet, S., Ricard, L., Jardin, F., Rubio, M., Schmidt, A., Damaj, G., Carras, S., Bay, J., Lebras, L., Joris, M., Herbreteau, L., Abraham, J., Fouillet, L., Chauchet, A., Malfuson, J., Hermine, O., Guffroy, B., Decroocq, J., Gouill, S. L., Tessoulin, B. (2025). Comparison of axi-cel versus liso-cel as 2nd line therapy for relapsed/refractory large B-cell lymphoma in real-life: A lysa study from the descar-T registry. Blood. https://doi.org/10.1182/blood-2025-127